Document Detail

Synthesis of cytochrome c oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell death.
MedLine Citation:
PMID:  22120717     Owner:  NLM     Status:  Publisher    
P53 has an important role in the processing of starvation signals. P53-dependent molecular mediators of the Warburg effect reduce glucose consumption and promote mitochondrial function. We therefore hypothesized that the retention of wild-type p53 characteristic of primary glioblastomas limits metabolic demands induced by deregulated signal transduction in the presence of hypoxia and nutrient depletion. Here we report that short hairpin RNA-mediated gene suppression of wild-type p53 or ectopic expression of mutant temperature-sensitive dominant-negative p53(V135A) increased glucose consumption and lactate production, decreased oxygen consumption and enhanced hypoxia-induced cell death in p53 wild-type human glioblastoma cells. Similarly, genetic knockout of p53 in HCT116 colon carcinoma cells resulted in reduced respiration and hypersensitivity towards hypoxia-induced cell death. Further, wild-type p53 gene silencing reduced the expression of synthesis of cytochrome c oxidase 2 (SCO2), an effector necessary for respiratory chain function. An SCO2 transgene reverted the metabolic phenotype and restored resistance towards hypoxia in p53-depleted and p53 mutant glioma cells in a rotenone-sensitive manner, demonstrating that this effect was dependent on intact oxidative phosphorylation. Supplementation with methyl-pyruvate, a mitochondrial substrate, rescued p53 wild-type but not p53 mutant cells from hypoxic cell death, demonstrating a p53-mediated selective aptitude to metabolize mitochondrial substrates. Further, SCO2 gene silencing in p53 wild-type glioma cells sensitized these cells towards hypoxia. Finally, lentiviral gene suppression of SCO2 significantly enhanced tumor necrosis in a subcutaneous HCT116 xenograft tumor model, compatible with impaired energy metabolism in these cells. These findings demonstrate that glioma and colon cancer cells with p53 wild-type status can skew the Warburg effect and thereby reduce their vulnerability towards tumor hypoxia in an SCO2-dependent manner. Targeting SCO2 may therefore represent a valuable strategy to enhance sensitivity towards hypoxia and may complement strategies targeting glucose metabolism.Oncogene advance online publication, 28 November 2011; doi:10.1038/onc.2011.530.
C Wanka; D P Brucker; O Bähr; M Ronellenfitsch; M Weller; J P Steinbach; J Rieger
Related Documents :
9160877 - Use of the mtt assay in adult ventricular cardiomyocytes to assess viability: effects o...
2826957 - The inhibitory effect of forskolin on antibody-dependent cell-mediated cytotoxicity usi...
6300127 - Cyclic amp regulation of lactate dehydrogenase. isoproterenol and n6,o2-dibutyryl cycli...
29697 - Sif cells, cyclic amp responses, and catecholamines of the guinea pig superior cervical...
15046867 - The sigma receptor ligand (+)-pentazocine prevents apoptotic retinal ganglion cell deat...
20419107 - Activation of the akt survival pathway contributes to trail resistance in cancer cells.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-28
Journal Detail:
Title:  Oncogene     Volume:  -     ISSN:  1476-5594     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1] Dr Senckenberg Institute of Neurooncology, Goethe University Frankfurt, Frankfurt, Germany [2] Department of Neurology, University Hospital Tübingen, Tübingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Acetylation controls Notch3 stability and function in T-cell leukemia.
Next Document:  MiR-27b targets PPAR? to inhibit growth, tumor progression and the inflammatory response in neurobla...